Alpaca-derived antibodies could protect plants from disease science.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from science.org Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
CAMBRIDGE, Mass., Feb. 3, 2021 /PRNewswire/ Invaio Sciences, Inc., a Flagship Pioneering company focused on unlocking the potential of the planet s interdependent natural systems to solve pressing agriculture, nutrition and environmental challenges, announces today the appointment of new academic leaders as members to its Scientific Advisory Board (SAB). We are delighted to announce a distinguished group of star scholars of the systems of nature, who are joining our Scientific Advisory Board, says Gerardo Ramos, Invaio s Chief Scientific Officer. Invaio is tackling unsolved problems in agriculture with novel targeted approaches that deliver natural biological active molecules and solutions in balance with natural systems. When digitized at the macro- and micro-levels using advanced artificial intelligence and machine learning technologies, we are just at the cliff of vast breakthrough. The contribution of Invaio s new SAB members of
Share this article
Share this article
CAMBRIDGE, Mass., Jan. 7, 2021 /PRNewswire/ Senda Biosciences, a Flagship Pioneering company creating novel categories of medicines based on Intersystems Biology, today announced the formation of its Scientific Advisory Board (SAB). Senda s SAB is composed of leading experts across immunology, microbiology, biochemistry, and neurology, and will collaborate with Senda s leadership to support and advance the new research discipline of Intersystems Biology. This discipline focuses on how molecular connections among botanical, bacterial, and human cells coevolved over millennia define health and disease. We are thrilled to have attracted some of the brightest minds in their fields to our SAB, says Guillaume Pfefer, PhD, chief executive officer of Senda. The deep expertise of the SAB will be pivotal to the advancement of our novel approach to medicines development, rooted in an unparalleled understanding of interspecies molecular connections.